NCT04624958 2024-10-18Zanubrutinib and Rituximab Followed by R-DHAOx Then Maintenance with Zanubrutinib for Newly-Diagnosed MCLSun Yat-sen UniversityPhase 2 Active not recruiting42 enrolled